✦ LIBER ✦

Point mutations of Ha-ras and Ki-ras oncogenes in sputum specimens from lung cancer patients

✍ Scribed by He, Ling; Chen, Jia-kun; Yi, Fei; Wu, Zhong-liang; Du, Ying-xiu

Book ID: 121990738
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 137 KB
Volume: 14
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(96)90255-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Amplification and point mutation of the

Amplification and point mutation of the Ha-ras oncogene in lung cancer

✍ Chen, Jia-kun; He, Ling; Wu, Zhong-liang; Du, Ying-xiu 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Detection of point mutations in K-ras on

Detection of point mutations in K-ras oncogene in lung cancer

✍ P. Hackman; K. Husgafvel-Pursiainen; S. Anttila; M. Ridanpää; A. Karjalainen; L. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Occupational cancer genetics: infrequent

Occupational cancer genetics: infrequent ras oncogenes point mutations in lung cancer samples from chromate workers

✍ Ashraf A. Ewis; Kazuya Kondo; Juwon Lee; Masaru Tsuyuguchi; Masato Hashimoto; To 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

Ras oncogene mutations and survival in p

Ras oncogene mutations and survival in patients with lung cancer

✍ Ferretti, G; Felici, A; Cognetti, F 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 44 KB

725 Highly sensitive detection method (P

725 Highly sensitive detection method (Point-EXACCT) for K-ras point mutations in sputum from patients with lung cancer

✍ Somers, V.A.M.C.; Pietersen, A.; Theunissen, P.H.; Thunnissen, F.B.J.M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

K-ras mutation in sputum of patients wit

K-ras mutation in sputum of patients with or without lung cancer

✍ Ze'ev Ronai; Marina S. Yabubovskaya; Edith Zhang; Gennady A. Belitsky 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

K-ras mutation appears in about 60% of patients with non-small-cell lung cancer (NSCLC). This freqLency and its presence in normal appearing tissues point to the potential of ras oncogene mutation to serve as a good biomarker. Using enriched PCR (EPCR), which enables the detection of one mutant alle